Rafferty Asset Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-24,912
| Closed | -$780K | – | 1118 |
|
2023
Q1 | $780K | Sell |
24,912
-9,963
| -29% | -$312K | 0.01% | 855 |
|
2022
Q4 | $2.46M | Buy |
34,875
+10,416
| +43% | +$733K | 0.02% | 519 |
|
2022
Q3 | $2.11M | Buy |
+24,459
| New | +$2.11M | 0.02% | 499 |
|
2022
Q2 | – | Sell |
-13,735
| Closed | -$2.28M | – | 1181 |
|
2022
Q1 | $2.28M | Buy |
13,735
+6,953
| +103% | +$1.16M | 0.01% | 564 |
|
2021
Q4 | $1.13M | Buy |
+6,782
| New | +$1.13M | 0.01% | 814 |
|